
Researchers have made significant progress in diabetes treatment with a new method developed. By redirecting primary human gastric stem cells derived from stomach tissue, they could generate insulin-producing β-cells. This breakthrough offers hope for patients with type 1 diabetes, providing a potential alternative to pancreatic islet cell replacement therapy. The technique could overcome the challenges of organ donor scarcity and the need for immunosuppression, making it a promising strategy for wider application.
Like
Save
Share